Innate Immunity and Transcription of MGAT-III and Toll-like Receptors in Alzheimer's Disease Patients Are Improved by Bisdemethoxycurcumin

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2007 Jul 27

PMID 17652175

Citations 91

Authors

Milan Fiala

Philip T Liu

Araceli Espinosa-Jeffrey

Mark J Rosenthal

George Bernard

John M Ringman

James Sayre

Laura Zhang

Justin Zaghi

Sheila Dejbakhsh

Ben Chiang

James Hui

Michelle Mahanian

Anita Baghaee

Pamela Hong

John Cashman

Affiliations

Soon will be listed here.

Abstract

We have tested a hypothesis that the natural product curcuminoids, which has epidemiologic and experimental rationale for use in AD, may improve the innate immune system and increase amyloid-beta (Abeta) clearance from the brain of patients with sporadic Alzheimer's disease (AD). Macrophages of a majority of AD patients do not transport Abeta into endosomes and lysosomes, and AD monocytes do not efficiently clear Abeta from the sections of AD brain, although they phagocytize bacteria. In contrast, macrophages of normal subjects transport Abeta to endosomes and lysosomes, and monocytes of these subjects clear Abeta in AD brain sections. Upon Abeta stimulation, mononuclear cells of normal subjects up-regulate the transcription of beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (MGAT3) (P < 0.001) and other genes, including Toll like receptors (TLRs), whereas mononuclear cells of AD patients generally down-regulate these genes. Defective phagocytosis of Abeta may be related to down-regulation of MGAT3, as suggested by inhibition of phagocytosis by using MGAT3 siRNA and correlation analysis. Transcription of TLR3, bditTLR4, TLR5, bditTLR7, TLR8, TLR9, and TLR10 upon Abeta stimulation is severely depressed in mononuclear cells of AD patients in comparison to those of control subjects. In mononuclear cells of some AD patients, the curcuminoid compound bisdemethoxycurcumin may enhance defective phagocytosis of Abeta, the transcription of MGAT3 and TLRs, and the translation of TLR2-4. Thus, bisdemethoxycurcumin may correct immune defects of AD patients and provide a previously uncharacterized approach to AD immunotherapy.

Citing Articles

Immune mechanisms and shared immune targets in neurodegenerative diseases.

Weiner H Nat Rev Neurol. 2024; 21(2):67-85.

PMID: 39681722 DOI: 10.1038/s41582-024-01046-7.

Correlation between Blood Monocytes and CSF Tau in Alzheimer's Disease: The Effect of Gender and Cognitive Decline.

Cimiotti C, Paganetti P, Rossi S, Soldini E, Sacco L NeuroSci. 2024; 4(4):319-330.

PMID: 39484180 PMC: 11523745. DOI: 10.3390/neurosci4040026.

COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals.

De Souza Goncalves B, Sangani D, Nayyar A, Puri R, Irtiza M, Nayyar A Int J Mol Sci. 2024; 25(15).

PMID: 39126050 PMC: 11312872. DOI: 10.3390/ijms25158481.

Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease.

Dover M, Moseley T, Biskaduros A, Paulchakrabarti M, Hwang S, Hammock B J Alzheimers Dis. 2022; 91(1):245-261.

PMID: 36373322 PMC: 9881025. DOI: 10.3233/JAD-220764.

Current Naturopathy to Combat Alzheimer's Disease.

Chakrovorty A, Bhattacharjee B, Saxena A, Samadder A, Nandi S Curr Neuropharmacol. 2022; 21(4):808-841.

PMID: 36173068 PMC: 10227918. DOI: 10.2174/1570159X20666220927121022.

References

Shigeta M, Shibukawa Y, Ihara H, Miyoshi E, Taniguchi N, Gu J . beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells. Glycobiology. 2006; 16(6):564-71. DOI: 10.1093/glycob/cwj100. View

DAndrea M, Cole G, Ard M . The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging. 2004; 25(5):675-83. DOI: 10.1016/j.neurobiolaging.2003.12.026. View

Bard F, Cannon C, Barbour R, Burke R, Games D, Grajeda H . Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000; 6(8):916-9. DOI: 10.1038/78682. View

Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

Licastro F, Porcellini E, Caruso C, Lio D, Corder E . Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging. 2006; 28(11):1637-43. DOI: 10.1016/j.neurobiolaging.2006.07.007. View

Bitan G, Fradinger E, Spring S, Teplow D . Neurotoxic protein oligomers--what you see is not always what you get. Amyloid. 2005; 12(2):88-95. DOI: 10.1080/13506120500106958. View

Bhattacharyya R, Bhaumik M, Shantha Raju T, Stanley P . Truncated, inactive N-acetylglucosaminyltransferase III (GlcNAc-TIII) induces neurological and other traits absent in mice that lack GlcNAc-TIII. J Biol Chem. 2002; 277(29):26300-9. DOI: 10.1074/jbc.M202276200. View

Cataldo A, Hamilton D, Nixon R . Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 1994; 640(1-2):68-80. DOI: 10.1016/0006-8993(94)91858-9. View

Cutler R, Kelly J, Storie K, Pedersen W, Tammara A, Hatanpaa K . Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A. 2004; 101(7):2070-5. PMC: 357053. DOI: 10.1073/pnas.0305799101. View

10.

Cataldo A, Hamilton D, Barnett J, Paskevich P, Nixon R . Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci. 1996; 16(1):186-99. PMC: 6578706. View

11.

Renn C, Sanchez D, Ochoa M, Legaspi A, Oh C, Liu P . TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J Immunol. 2006; 177(1):298-305. DOI: 10.4049/jimmunol.177.1.298. View

12.

Mattson M . Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal. 2006; 8(11-12):1997-2006. DOI: 10.1089/ars.2006.8.1997. View

13.

Rogaeva E, Meng Y, Lee J, Gu Y, Kawarai T, Zou F . The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007; 39(2):168-77. PMC: 2657343. DOI: 10.1038/ng1943. View

14.

Monney L, Sabatos C, Gaglia J, Ryu A, Waldner H, Chernova T . Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002; 415(6871):536-41. DOI: 10.1038/415536a. View

15.

Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M . Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2006; 10(1):1-7. DOI: 10.3233/jad-2006-10101. View

16.

Forman M, Trojanowski J, Lee V . Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med. 2004; 10(10):1055-63. DOI: 10.1038/nm1113. View

17.

Taniguchi N, Miyoshi E, Ko J, Ikeda Y, Ihara Y . Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta. 1999; 1455(2-3):287-300. DOI: 10.1016/s0925-4439(99)00066-6. View

18.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G . Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21(3):383-421. PMC: 3887148. DOI: 10.1016/s0197-4580(00)00124-x. View

19.

Rhodes J, Bowser R . Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease. Mech Ageing Dev. 2001; 123(1):11-20. DOI: 10.1016/s0047-6374(01)00334-7. View

20.

Takeda K, Kaisho T, Akira S . Toll-like receptors. Annu Rev Immunol. 2003; 21:335-76. DOI: 10.1146/annurev.immunol.21.120601.141126. View